protozoa infectious disease
protozoa infectious disease
Explore linked clinical trials. Standard reference: MONDO:0002428172 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not applicable | 2026-10-09 | NCT07859800 | |
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 | |
| Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT02471378 | |
| Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali | Body Temperature Changes, Fever, Infections, Mosquito-Borne Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT01168271 | |
| Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan | Euglenozoa Infections, Infections, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, anxiety, anxiety disorder, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, psychiatric disorder, skin disorder, skin disorder caused by infection, vector-borne disease | Not yet recruiting | Not applicable | 2026-10-05 | NCT07858357 | |
| First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-10-05 | NCT07646353 | |
| Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, malaria, parasitic infectious disease, protozoa infectious disease, sickle cell disease, thalassemia, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT03937817 | |
| Diagnosis and Treatment of Leishmania Infections | Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, mucocutaneous leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease, visceral leishmaniasis | Recruiting | Not stated | 2026-10-02 | NCT00344188 | |
| Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection | Infections, Mosquito-Borne Diseases, Trematode Infections, helminthiasis, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT00001645 | |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-10-01 | NCT06666491 | |
| Parasitic Ulcer Treatment Trial | Acanthamoeba keratitis, Infections, amebiasis, corneal disorder, corneal ulcer, eye disorder, eye infectious disorder, keratitis, parasitic eye infection, parasitic infectious disease, protozoa infectious disease | Recruiting | Phase 3 | 2026-10-01 | NCT06213649 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Nitazoxanide for Treatment of Cryptosporidium in Children | Digestive System Diseases, Infections, coccidiosis, cryptosporidiosis, digestive system disorder, intestinal disorder, non-human animal disease, parasitic disease, non-human animal, parasitic infectious disease, parasitic intestinal disorder, protozoa infectious disease, protozoan infections, animal | Not yet recruiting | Phase 3 | 2026-09-28 | NCT06600711 | |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-09-25 | NCT07840898 | |
| Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07831226 | |
| Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays | Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, malaria, parasitemia, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-09-25 | NCT06607003 | |
| Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-09-24 | NCT07758985 | |
| Tafenoquine Drug Levels in Small Children | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07835321 | |
| IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Not applicable | 2026-09-22 | NCT06870344 | |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-09-18 | NCT06923592 | |
| Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-15 | NCT07819825 | |
| A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. | Chagas disease, Euglenozoa Infections, Infections, parasitic infectious disease, protozoa infectious disease, trypanosomiasis, vector-borne disease | Recruiting | Phase 2 | 2026-09-15 | NCT06632600 | |
| Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 4 | 2026-09-11 | NCT07246525 | |
| Platelet-Directed Whole Blood Transfusion Strategy for Malaria | Cytopenia, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, blood platelet disease, hematologic disorder, malaria, parasitic infectious disease, protozoa infectious disease, thrombocytopenia, vector-borne disease | Recruiting | Not applicable | 2026-09-11 | NCT05711485 | |
| Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-09-10 | NCT07811908 |